Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05059535
Other study ID # 2021-A01321-40
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date January 12, 2022
Est. completion date October 2025

Study information

Verified date November 2023
Source GCS Ramsay Santé pour l'Enseignement et la Recherche
Contact Mourad MD AÏSSOU
Phone +33625650434
Email aissou.mourad.sat@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Interventional, comparative, randomized, controlled study versus standard treatment, in 3 parallel groups, monocentric, aiming to demonstrate the superiority of preoperative cryoneurolysis versus no procedure, in patients operated on for knee arthroplasty and receiving standard analgesia.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date October 2025
Est. primary completion date October 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Age = 18 years and = 80 years; - Patient to undergo prosthetic knee surgery; - Patient in good health (ASA score 1 to 3); - Patient able to understand the information related to the study, read the information leaflet and agree to sign the consent form. Exclusion Criteria: - Known intolerance to any of the products administered during surgery or cryoneurolysis; - Patient with an electric implant; - Patient with a contraindication to cryoanalgesia (coagulation disorders, infections, nerve damage); - Drug addict patient; - Intervention on septic bone; - Chronic renal failure (creatinine clearance <30 mL / min); - History of cryoglobulinemia, cold urticaria or Raynaud's syndrome; - Pregnant or breastfeeding woman; - Patient under guardianship or curatorship, or under a regime of deprivation of liberty; - Patient participating in another clinical trial, or in a period of exclusion from another clinical trial; - Patient not beneficiary of a social security scheme.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
standard pain relievers
Knee arthroscopy will be performed ansd patients will receive standard pain relievers in confomtity with the current practice

Locations

Country Name City State
France Hôpital privé Paul d'Egine Champigny-sur-marne

Sponsors (1)

Lead Sponsor Collaborator
GCS Ramsay Santé pour l'Enseignement et la Recherche

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary 90 ° flexion pain 2 days after the arthroscopy Evaluation of the knee pain at 90° flexion with a visual analogic scale of 100 mm 2 days
Secondary 90 ° flexion pain 1 day after the arthroscopy Evaluation of the knee pain at 90° flexion with a visual analogic scale of 100 mm 1 day
Secondary 90 ° flexion pain 7 days after the arthroscopy Evaluation of the knee pain at 90° flexion with a visual analogic scale of 100 mm 7 days
Secondary 90 ° flexion pain 30 days after the arthroscopy Evaluation of the knee pain at 90° flexion with a visual analogic scale of 100 mm 30 days
Secondary 90 ° flexion pain 90 days after the arthroscopy Evaluation of the knee pain at 90° flexion with a visual analogic scale of 100 mm 90 days
Secondary pain at rest at Day 1 Knee pain after intervention with a visual analogic scale of 100 mm 1 day
Secondary pain at rest at Day 2 Knee pain after intervention with a visual analogic scale of 100 mm 2 days
Secondary pain at rest at Day 7 Knee pain after intervention with a visual analogic scale of 100 mm 7 days
Secondary pain at rest at Day 30 Knee pain after intervention with a visual analogic scale of 100 mm 30 days
Secondary pain at rest at Day 90 Knee pain after intervention with a visual analogic scale of 100 mm 90 days
See also
  Status Clinical Trial Phase
Recruiting NCT04554212 - Blood Flow Restriction Training After Patellar INStability N/A
Completed NCT04815980 - Impact of Pilates on Running Mechanics N/A
Not yet recruiting NCT05484778 - Analysis of Balance and Functional Hop Tests Used for Return to Sports in Athletes With Lower Extremity Injuries by Dual Task Study N/A
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4
Completed NCT02540811 - Clinical Evaluation of dCELL® ACL Scaffold for Reconstruction of the Anterior Cruciate Ligament N/A
Recruiting NCT03755388 - Clinical Trial of an MRI Based Patient Specific Focal Knee Resurfacing Implant N/A
Recruiting NCT00174213 - Validity and Reliability in Measuring Iliotibial Tract by Using Ultrasound Phase 1
Completed NCT03202901 - Accute Effect of B-Turmactive Both on Mild and Moderate Knee Pain on Healthy Volunteers N/A
Completed NCT06206018 - Patient-Reported Outcome Measures in Lower Extremity Rehabilitation Program PROM_R: Impact on Health Care N/A
Completed NCT04543227 - Opioid Laws and Pediatric Use
Completed NCT06078072 - Biomaterials and Mesenchymal Stem/Stromal Cells in the Treatment of Knee Articular Surface Lesions
Completed NCT04956393 - The SOAR (Stop OsteoARthritis) Program Proof-of-Concept Study N/A
Recruiting NCT06451510 - Knee Osteoarthritis in the Region of Norrbotten
Completed NCT04118023 - 7T MRI to Evaluate Cartilage Defects in the Knee
Completed NCT03486405 - A Randomized Control Trial: Returning to Run After Injury N/A
Recruiting NCT03858231 - Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery Phase 4
Recruiting NCT02918734 - Fixation of Patellar Tendon Grafts in Anterior Cruciate Ligament Reconstruction. Endobutton vs Metal Interference Screws N/A
Suspended NCT02270905 - Clinical Evaluation of dCELL® Meniscus for Partial Replacement of the Meniscus N/A
Completed NCT01227694 - Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis Phase 1/Phase 2
Completed NCT00991588 - Clinical Outcome of Posterior Cruciate Ligament (PCL) Posterolateral Reconstruction